Thermo Electron Business to Sell Modified Ion Trap Mass Spectrometers in Germany

Apr 20, 2001, 01:00 ET from Thermo Electron

    WALTHAM, Mass., April 20 //PRNewswire Interactive Release/ -- Thermo
 Electron (NYSE:   TMO) announced today that its Thermo Finnigan business has
 introduced three modified ion trap mass spectrometry products -- the PolarisQ,
 the LCQ(TM) Deca XP, and the LCQ(TM) Advantage -- for the German market.
 Thermo Finnigan modified its ion trap products for sale in Germany after a
 recent patent ruling in favor of its competitor, Bruker Daltonics. These
 products will be available immediately to German customers.
     (Photo: http://www.newscom.com/cgi-bin/prnh/20001030/TMOLOGO)
     "We are confident that our modifications address the concerns raised in
 the German court case," said Colin Maddix, president of Thermo Electron's Life
 Sciences sector. "While we were surprised by the ruling, our customers' needs
 come first. We moved quickly on the modifications to ensure that German
 customers who depend on our products can obtain them without interruption.
 These modified products, of course, continue to live up to our exacting
 standards of quality and our customers' high expectations."
     Mr. Maddix added, "Obviously, patent cases like these are very
 complicated, and the outcomes are subject to appeal. It's very difficult to
 predict how a court will rule. In fact, the same German court that recently
 found in favor of Bruker determined in separate proceedings last year that
 Bruker had infringed upon one of our key ion trap patents. On the other hand,
 a court in Boston ruled yesterday that Bruker had not infringed upon a claim
 of another patent. None of these court actions affects our ability to sell ion
 traps outside Germany.
     "Ultimately, this competition will take place in the marketplace. Since
 shipping our first ion trap product in 1983, we've been the leader in ion trap
 technology. We're confident that our ion traps are the highest throughput
 instruments -- the tool-of-choice for proteomic and other researchers. In the
 marketplace, we believe we have the clear advantage."
     Thermo Electron Corporation is a global leader in providing technology-
 based instruments, components, and systems that offer total solutions for
 markets ranging from life sciences to telecommunications to food, drug, and
 beverage production. The company's powerful technologies help researchers sift
 through data to make discoveries that will fight disease or prolong life. They
 allow manufacturers to fabricate ever-smaller components required to increase
 the speed and quality of communications. And they automatically monitor and
 control online production to ensure that critical quality standards are met
 safely and efficiently. In 2000, Thermo Electron's instrument businesses,
 based in Waltham, Massachusetts, reported $2.3 billion in revenues and
 employed approximately 13,000 people worldwide. For more information on Thermo
 Electron, visit http://www.thermo.com.
     The following constitutes a "Safe Harbor" statement under the Private
 Securities Litigation Reform Act of 1995: This press release contains forward-
 looking statements that involve a number of risks and uncertainties. Important
 factors that could cause actual results to differ materially from those
 indicated by such forward-looking statements are set forth under the heading
 "Risk Factors" in the company's Annual Report on Form 10-K for the fiscal year
 ended December 30, 2000.
     These include risks and uncertainties relating to: integration of the
 company's instrument businesses, the ability to improve internal growth,
 liquidity and prospective performance of the subsidiaries to be spun off, the
 company's guarantee of obligations of the subsidiaries to be spun off, the
 effect of exchange rate fluctuations on international operations, potential
 impairment of goodwill, the need to develop new products and adapt to
 significant technological change, dependence on customers that operate in
 cyclical industries, the effect of changes in governmental regulations, and
 dependence on customers' capital spending policies and government funding
 policies.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X76531662
 
 

SOURCE Thermo Electron
    WALTHAM, Mass., April 20 //PRNewswire Interactive Release/ -- Thermo
 Electron (NYSE:   TMO) announced today that its Thermo Finnigan business has
 introduced three modified ion trap mass spectrometry products -- the PolarisQ,
 the LCQ(TM) Deca XP, and the LCQ(TM) Advantage -- for the German market.
 Thermo Finnigan modified its ion trap products for sale in Germany after a
 recent patent ruling in favor of its competitor, Bruker Daltonics. These
 products will be available immediately to German customers.
     (Photo: http://www.newscom.com/cgi-bin/prnh/20001030/TMOLOGO)
     "We are confident that our modifications address the concerns raised in
 the German court case," said Colin Maddix, president of Thermo Electron's Life
 Sciences sector. "While we were surprised by the ruling, our customers' needs
 come first. We moved quickly on the modifications to ensure that German
 customers who depend on our products can obtain them without interruption.
 These modified products, of course, continue to live up to our exacting
 standards of quality and our customers' high expectations."
     Mr. Maddix added, "Obviously, patent cases like these are very
 complicated, and the outcomes are subject to appeal. It's very difficult to
 predict how a court will rule. In fact, the same German court that recently
 found in favor of Bruker determined in separate proceedings last year that
 Bruker had infringed upon one of our key ion trap patents. On the other hand,
 a court in Boston ruled yesterday that Bruker had not infringed upon a claim
 of another patent. None of these court actions affects our ability to sell ion
 traps outside Germany.
     "Ultimately, this competition will take place in the marketplace. Since
 shipping our first ion trap product in 1983, we've been the leader in ion trap
 technology. We're confident that our ion traps are the highest throughput
 instruments -- the tool-of-choice for proteomic and other researchers. In the
 marketplace, we believe we have the clear advantage."
     Thermo Electron Corporation is a global leader in providing technology-
 based instruments, components, and systems that offer total solutions for
 markets ranging from life sciences to telecommunications to food, drug, and
 beverage production. The company's powerful technologies help researchers sift
 through data to make discoveries that will fight disease or prolong life. They
 allow manufacturers to fabricate ever-smaller components required to increase
 the speed and quality of communications. And they automatically monitor and
 control online production to ensure that critical quality standards are met
 safely and efficiently. In 2000, Thermo Electron's instrument businesses,
 based in Waltham, Massachusetts, reported $2.3 billion in revenues and
 employed approximately 13,000 people worldwide. For more information on Thermo
 Electron, visit http://www.thermo.com.
     The following constitutes a "Safe Harbor" statement under the Private
 Securities Litigation Reform Act of 1995: This press release contains forward-
 looking statements that involve a number of risks and uncertainties. Important
 factors that could cause actual results to differ materially from those
 indicated by such forward-looking statements are set forth under the heading
 "Risk Factors" in the company's Annual Report on Form 10-K for the fiscal year
 ended December 30, 2000.
     These include risks and uncertainties relating to: integration of the
 company's instrument businesses, the ability to improve internal growth,
 liquidity and prospective performance of the subsidiaries to be spun off, the
 company's guarantee of obligations of the subsidiaries to be spun off, the
 effect of exchange rate fluctuations on international operations, potential
 impairment of goodwill, the need to develop new products and adapt to
 significant technological change, dependence on customers that operate in
 cyclical industries, the effect of changes in governmental regulations, and
 dependence on customers' capital spending policies and government funding
 policies.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X76531662
 
 SOURCE  Thermo Electron

RELATED LINKS

http://www.thermo.com